ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,855, issued on Sept. 16, was assigned to Tesaro Inc. (Waltham, Mass.).

"Methods of treating cancer with anti-PD-1 antibodies" was invented by David Jenkins (Waltham, Mass.), Haley A. Laken (Waltham, Mass.), Ellie Im (Waltham, Mass.), Allene Diaz (Waltham, Mass.) and Sharon Lu (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods of administering certain PD-1 binding agents to patients having cancer. Dosage regimens for compositions comprising a PD-1 binding agent are also explicitly provided."

The patent was filed on July 15, 2022, under Application No. 17/812,933.

*For further information, includin...